Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of an Accelerated Vaccination Schedule With a Zika Virus Purified Inactivated Vaccine Plus Alum Adjuvant in Healthy Adults

Next Previous
X
Search
Trial Profile

A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of an Accelerated Vaccination Schedule With a Zika Virus Purified Inactivated Vaccine Plus Alum Adjuvant in Healthy Adults

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Zika virus vaccine-Sanofi (Primary) ; Aluminium hydroxide
  • Indications Zika virus infection
  • Focus Adverse reactions

    • Most Recent Events

    • 01 Sep 2020 At study initiation, analysis of the endpoints at 6 months was planned to take place on day 180 (week 26), but this timepoint was amended on 27 Feb 2017, to day 196 (week 28) to harmonise timepoints with other concurrent trials on the ZPIV vaccine.
    • 01 Sep 2020 According to results published in The Lancet Infectious Diseases, the Henry M Jackson Foundation for the Advancement of Military Medicine is the funder of the study.
    • 01 Sep 2020 Results published in The Lancet Infectious Diseases

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top